Answers are grounded in this paper and cite their sources.
This is the first study to describe dosing, time to discontinuation, and adverse effects of mexiletine in a complete cohort of patients for migraine treatment.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: